Semaglutide has years of safety information
We applied consistent inclusion and exclusion criteria throughout all analyses and conducted multiple sensitivity assessments, including BMI-stratified subgroup analyses and clinical characteristic stratification, to verify the robustness of our findings across different patient populations
That said, the current medical guidance is to stop GLP-1s immediately after learning youre pregnant
In November 2023, the FDA granted approval for Zepbound (tirzepatide) for chronic weight management in adults with obesity (body mass index 30 kg/m) or overweight (BMI 27 kg/m) with at least one weight-related comorbid condition such as hypertension, dyslipidemia, type 2 diabetes, obstructive sleep apnea, or cardiovascular disease
If youve already lost weight on a GLP-1, your healthcare provider can document that you met the eligibility requirements when you began treatment
By enhancing the action of GLP-1, these medications help you: Feel Full Faster : So you naturally eat less